![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1520623
¼¼°èÀÇ ÃÊÀ½ÆÄ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå Æò°¡ : Á¦Ç° À¯Çüº°, °øÁ¤º°, ÇÁ·Îºê À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, ±âȸ ¹× ¿¹Ãø(2017-2031³â)Ultrasound Probe Disinfection Market Assessment, By Product, By Process, By Probe Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
¼¼°è ÃÊÀ½ÆÄ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå ±Ô¸ð´Â 2023³â 5¾ï 2,961¸¸ ´Þ·¯¿¡¼ 2031³â 12¾ï 8,622¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 11.73% ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ½ÃÀå ¼ºÀåÀº Àӽмö Áõ°¡, ½ÅÀå °á¼® ȯÀÚ Áõ°¡, º´¿ø ³» °¨¿° ȯÀÚ Áõ°¡, ÀÇ·á »ê¾÷ÀÇ ¹ßÀü¿¡ ÀÇÇØ µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù.
ÀÇ·á Æ®·»µåÀÇ ÁøÈ·Î ÀÎÇØ ÈÞ´ë °¡´ÉÇϰí È¿°úÀûÀÎ ÃÊÀ½ÆÄ ÇÁ·Îºê ¼Òµ¶ ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÇ·á ºÎ¹®ÀÇ µðÁöÅÐȰ¡ ÁøÇàµÊ¿¡ µû¶ó ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý Áø·áÀÇ ÀαⰡ ºü¸£°Ô Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÇ·á ¼ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ÀçÆíµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àαâ Áõ°¡´Â ¿ø°Ý ÀÇ·á¿Í ¿ø°Ý Ä¡·á°¡ Á¦°øÇÏ´Â ºñ¿ë ¹× ½Ã°£ È¿À²¼º ¶§¹®ÀÎ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼±È£µµÀÇ º¯È´Â »ç¿ëÀÚ Ä£ÈÀûÀ̰í ÈÞ´ë°¡ °£ÆíÇÏ¸ç ´Ù¾çÇÑ È¯°æ¿¡¼ È¿°úÀûÀ¸·Î ÀÛµ¿ÇÒ ¼ö ÀÖ´Â ÃÊÀ½ÆÄ ÇÁ·Îºê ¼Òµ¶ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
¶ÇÇÑ, ÀÇ·á ºÎ¹®ÀÇ ±Þ¼ÓÇÑ ¼ºÀå°ú ÀÇ·á ½Ã¼³ÀÇ ¸ê±Õ ¹× ¼Òµ¶¿¡ ´ëÇÑ ÁöħÀÌ °ÈµÇ°í ÀÖ´Â °Íµµ ½ÃÀå È®´ëÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è ¿©·¯ Áö¿ª¿¡¼ º´¿ø ³» °¨¿°ÀÇ À§ÇùÀÌ Áõ°¡Çϰí ÀÔ¿øÀÇ Çʿ伺ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÃÊÀ½ÆÄ ÇÁ·Îºê¸¦ ¼Òµ¶ÇÏ´Â ´Ù¾çÇÑ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, National Center for Health StatisticsÀÇ ÃßÁ¤¿¡ µû¸£¸é ȯÀÚÀÇ ¾à 7.9 .9%°¡ º´¿ø¿¡¼ ÇÏ·í¹ã µ¿¾È ÀÔ¿øÇØ¾ß ÇÕ´Ï´Ù.
¶ÇÇÑ, ÃÊÀ½ÆÄ ½Ã¼úÀ» Æ÷ÇÔÇÑ ÀæÀº ÀÇ·á ¿µ»ó Áø´ÜÀ» ÇÊ¿ä·Î ÇÏ´Â ´Ù¾çÇÑ ¸¸¼º Áúȯ ¹× Àå¾ÖÀÇ À¯º´·ü Áõ°¡´Â ½ÃÀå È®´ë¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÇ·á±â±âÀÇ ÀûÀýÇÑ ¼Òµ¶Àº ÀÇ·áÁøÀÌ Á¤È®ÇÑ Áø´ÜÀ» ³»¸®¸é¼ ȯÀÚÀÇ ½ÅüÀû, Á¤½ÅÀû °Ç°À» À¯ÁöÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù.
Ãâ»êÀ² Áõ°¡°¡ ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇÕ´Ï´Ù.
Àӽмö Áõ°¡´Â ¼¼°è ÃÊÀ½ÆÄ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖÀ¸¸ç, National Center for Health StatisticsÀÇ ÃßÁ¤¿¡ µû¸£¸é 2023³â ¹Ì±¹ÀÇ ÀÏ¹Ý Ãâ»ý·üÀº 15 - 44 ¼¼ ¿©¼º 1,000 ¸í´ç 54.4 ¸íÀ¸·Î ÀáÁ¤ Ãâ»ý¾Æ ¼ö´Â 359 ¸¸ 1, 328 ¸íÀ¸·Î ÃßÁ¤µË´Ï´Ù. 328¸íÀ̾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀ¸·Î ÀÎÇØ ÃÊÀ½ÆÄ °Ë»çÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÃÊÀ½ÆÄ °Ë»ç´Â ºñħ½ÀÀûÀ̰í ÅëÁõÀÌ ¾ø´Â ºñħ½ÀÀû ½Ã¼ú·Î Àǻ簡 žÆÀÇ ¹ß´ÞÀ» È®ÀÎÇϰí, ÀÌ»ó À¯¹«¸¦ °¨ÁöÇϰí, ¿©·¯ žÆÀÇ Á¸À縦 È®ÀÎÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù. žÆÀÇ ÀÌ»óÀ» Àû½Ã¿¡ ¹ß°ßÇϸé ÀÇ»ç´Â À¶¸ð¸· À¶¸ð »ùÇøµ, ¾ç¼ö õÀÚ µî Ãß°¡ °Ë»ç¸¦ ÅëÇØ Áø´ÜÀ» °ÅºÎÇϰųª È®ÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ¶§¹®¿¡ ÃÊÀ½ÆÄ °Ë»çÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå È®´ë¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.
¶ÇÇÑ, ÀӽŠȽ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¼öÁ¤¶õÀÌ Àڱà ¹Û¿¡¼ ÀÚ¶ó´Â »óŸ¦ °¨ÁöÇϱâ À§ÇÑ ÃÊÀ½ÆÄ °Ë»çµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áõ°¡·Î ÀÎÇØ ȯÀÚ¿¡°Ô ÀûÀýÇÑ Ä¡·á¸¦ Á¦°øÇÏ°í °¨¿° È®»êÀ» ¹æÁöÇϱâ À§ÇØ ÃÊÀ½ÆÄ ÇÁ·Îºê ¼Òµ¶ Àåºñ ¹× ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
½ÅÀå °á¼® Áõ°¡·Î ½ÃÀå ¼ö¿ä Áõ°¡
Àü ¼¼°è ¿©·¯ Áö¿ª¿¡¼ ½ÅÀå °á¼® ¹ß»ýÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå¿¡ À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ½ÅÀå °á¼®°ú °ü·ÃµÈ ´Ù¾çÇÑ ¿øÀÎÀ¸·Î´Â Å»¼ö, °¡Á··Â, ¼³ÅÁ°ú ³ªÆ®·ýÀÌ ¸¹Àº ½Ä´Ü, ºñ¸¸ µîÀÌ ÀÖÀ¸¸ç, ¹Ì±¹ ½ÅÀå ±â±Ý(American Kidney Fund)Àº ¹Ì±¹ ¿©¼º 14¸í Áß 1¸í, ³²¼º 10¸í Áß 1¸í ÀÌ»óÀÌ Æò»ý µ¿¾È ½ÅÀå °á¼®¿¡ °É¸± °ÍÀ¸·Î ÃßÁ¤Çϰí ÀÖ½À´Ï´Ù. ÃÊÀ½ÆÄ °Ë»ç´Â ½ÅÀå °á¼® ¹× ±âŸ ½ÅÀå °ü·Ã ÁúȯÀ» Áø´ÜÇϰí ü¾× Àú·ù, Á¾¾ç, °¨¿°, ³¶Á¾, Æó»ö, ³ó¾ç µîÀ» °¨ÁöÇÒ ¼ö Àֱ⠶§¹®¿¡ ÀÌ·¯ÇÑ Áõ°¡·Î ÀÎÇØ ÃÊÀ½ÆÄ °Ë»çÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½Ã¼ú Áß »ý¼ºµÇ´Â ¿µ»óÀ» ÅëÇØ ÀÇ·áÁøÀº ½ÅÀåÀÇ À§Ä¡, Å©±â, ¸ð¾çÀ» Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·Î ÀÎÇØ Á¤±âÀûÀÎ ÃÊÀ½ÆÄ ½Ã¼úÀÇ Çʿ伺ÀÌ Áõ°¡ÇÏ¿© ¼¼°è ÃÊÀ½ÆÄ ÇÁ·Îºê ¼Òµ¶ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
ºÏ¹Ì°¡ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù.
¹Ì±¹ Áúº´¿¹¹æ ¹× °Ç°ÁõÁø±¹(Office of Disease Prevention and Health Promotion)ÀÇ Ã߻꿡 µû¸£¸é, ¹Ì±¹¿¡¼´Â ÀÔ¿ø ȯÀÚ 31¸í Áß 1¸í ÀÌ»óÀÌ º´¿ø ³» °¨¿°À» ¾Î°í ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ÀÔ¿ø ȯÀÚ 31¸í Áß 1¸íÀÌ º´¿ø ³» °¨¿°À» ¾Î°í ÀÖ´Ù°í ÇÕ´Ï´Ù. º´¿ø ³» °¨¿°Àº Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ(CDC)ÀÇ ±¹°¡ÀÇ·á¾ÈÀü³×Æ®¿öÅ©(NHSN) µî ´Ù¾çÇÑ ±â°ü¿¡¼ ¸ð´ÏÅ͸µÇϰí ÀÖ½À´Ï´Ù. º´¿ø ³» °¨¿°°ú °ü·ÃµÈ ÀáÀçÀûÀÎ À§ÇèÀ¸·Î ÀÎÇØ º´¿ø°ú °°Àº ÀÇ·á ±â°üÀº ÃÊÀ½ÆÄ ÇÁ·Îºê ¼Òµ¶¿¡ »ç¿ëµÇ´Â Àåºñ ¹× ¼ºñ½º äÅÃÀ» Æ÷ÇÔÇÏ¿© ÀÌ·¯ÇÑ °¨¿°·üÀ» ³·Ãß±â À§ÇØ ´Ù¾çÇÑ °¨¿° ¿¹¹æ ¹× ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ¹× ±â¼ú¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ ÃÊÀ½ÆÄ ÇÁ·Îºê ¼Òµ¶ÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ºÏ¹Ì ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ¼¼°è ÃÊÀ½ÆÄ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, ½ÃÀå ¿ªÇÐ, ÁÖ¿ä ±â¾÷ ÇöȲ ¹× Àü¸Á µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
Global ultrasound probe disinfection market is projected to witness a CAGR of 11.73% during the forecast period 2024-2031F, growing from USD 529.61 million in 2023 to USD 1286.22 million in 2031F. The market's growth is supported by the increasing number of pregnancies, rising cases of kidney stones, growing cases of hospital-acquired infections, and the evolution of the healthcare industry.
Evolving healthcare trends are bolstering the requirement for portable and effective disinfection solutions for ultrasound probes. Due to increasing digitalization in the healthcare sector, the popularity of telehealth and telemedicine is rising rapidly, reshaping access to healthcare services. This growing popularity can be attributed to the cost and time efficiency provided by telehealth and telemedicine. This shift in preference is propelling the demand for ultrasound probe disinfection solutions that are user-friendly, portable, and can effectively work in diverse settings.
Additionally, the rapid expansion of the healthcare sector and the growing stringency of guidelines for sterilization and disinfection in healthcare facilities is another major factor aiding the market's expansion. The rising requirement for hospital stays coupled with the growing threat of hospital-acquired infections in various regions across the globe is further propelling the demand for different solutions for disinfecting ultrasound probes. According to estimates from the National Center for Health Statistics, approximately 7.9% of patients require overnight stays at the hospital.
Furthermore, the increasing prevalence of various chronic diseases and disorders that require frequent medical imaging, including ultrasound procedures, is positively influencing the expansion of the market. Proper disinfection of medical devices aids healthcare professionals in maintaining the health and well-being of their patients while conducting accurate diagnoses.
Increasing Birth Rate Supports Market Expansion
The increasing number of pregnancies is propelling the global ultrasound probe disinfection market demand. According to the National Center for Health Statistics estimates, the general fertility rate in the United States in 2023 was 54.4 births per 1,000 females of ages 15-44, and the provisional number of births was 3,591,328. This growth is propelling the requirement for ultrasound as the painless and non-invasive procedure allows doctors to check the development of the fetus, detect the presence of any abnormalities, and confirm the presence of more than one fetus. With the timely detection of fetal abnormalities, doctors can offer additional tests, such as chorionic villus sampling and amniocentesis to reject or confirm the diagnosis. Due to this, the requirement for ultrasound procedures is rising, which in turn is positively influencing the expansion of the market.
Additionally, due to the increasing number of pregnancies, ultrasound procedures are also rising to detect conditions where the fertilized egg is growing outside the uterus. Due to this increase, the demand for ultrasound probe disinfection equipment and consumables is augmenting to ensure that proper care is provided to patients and prevent the spread of infections.
Rising Incidences of Kidney Stones Boost Market Demand
The increasing incidences of kidney stones in various regions across the globe are providing lucrative growth opportunities to the market. The different causes associated with kidney stones include dehydration, family history, sugar and sodium-rich diets, and obesity, among others. The American Kidney Fund estimates that over 1 in 14 women and 1 in 10 men in the United States will have kidney stones over the course of their lives. This increase is propelling the requirement for ultrasound procedures as they aid in diagnosing kidney stones and other conditions related to kidneys by detecting fluid collection, tumors, infections, cysts, obstructions, and abscesses. The images produced during the procedures allow healthcare professionals to assess the location, size, and shape of the kidneys. Thus bolstering the requirement for routine ultrasound procedures and aiding the growth of the global ultrasound probe disinfection market.
North America Accounts for Significant Market Share
The growth of the market in the region is supported by increasing investments towards the healthcare sector, growing hospitalizations due to the rising prevalence of various infectious and chronic diseases, and augmenting cases of hospital-acquired infections. According to the estimates of the Office of Disease Prevention and Health Promotion, 1 in 31 patients in hospitals in the United States have at least hospital-acquired infection at any given time. The hospital-acquired infections are monitored by various agencies, including the National Healthcare Safety Network (NHSN) of the Center for Disease Control and Prevention (CDC). Due to the potential risks associated with hospital-acquired infections, hospitals, and other medical institutions invest in various infection prevention and surveillance systems and techniques to reduce the rate of these infections, including the adoption of equipment and services used for disinfecting ultrasound probes. The increasing awareness about the importance of ultrasound probe disinfection among both patients and healthcare providers also supports the market growth in North America.
Hospitals and Clinics Hold Significant Share of the Market
Increasing hospitalizations and rising requirements for diagnostic imaging solutions such as ultrasounds due to the growing threat of infectious and chronic diseases such as cancer are supporting the expansion of the market. The increasing requirement for ultrasound procedures is propels the requirement for ultrasound probe disinfection solutions from hospitals and clinics. This increase can be attributed to the rising cases of cancer, ectopic pregnancies, gallstones, and kidney stones, among others. As per the estimates of the American Cancer Society, 2,001,140 new cases and 611,720 deaths related to cancer are expected to occur in 2024 in the United States. This rise propels the requirement for ultrasound procedures as they are often used for detecting tumors that do not appear on X-rays and for guiding needles when conducting a biopsy. This, in turn, is bolstering the demand for equipment and services essential for disinfecting ultrasound probes, as proper disinfection of probes is essential for preventing the transmission of diseases.
Future Market Scenario (2024-2031F)
As per the global ultrasound probe disinfection market analysis, the market is expected to witness significant growth opportunities in the coming years due to the rising requirement for ultrasound procedures because of the growing threat of chronic diseases.
The rising number of pregnancies is expected to boost the global ultrasound probe disinfection market size. This is because increasing cases of pregnancy will augment the requirement for ultrasound procedures, which in turn will augment the requirement for disinfection of ultrasound probes to ensure the health and safety of the patient and the fetus.
Moreover, automation in high-level disinfection of ultrasound probes is expected to aid in enhancing productivity and efficiency while providing a wide range of benefits for both patients and healthcare professionals alike. It is also expected to optimize standardization and scalability and improve compliance with different regulatory standards and guidelines, ensuring safer outcomes for patients as well as clinicians.
Ultraviolet-C (UV-C) light technology is anticipated to emerge as a useful tool for disinfecting ultrasound probes as the technology aids in destroying pathogens, bacteria, and viruses effectively. The portable and compact nature of these disinfection devices are expected to enhance user convenience and ensure quick turnaround between procedures.
Key Players Landscape and Outlook
Increasing investments are aiding the key players of the market to finance research and development activities and expand their footprint on a global scale. In March 2022, GERMITEC announced the appointment of a new management team and the completion of a financing round of USD 11.78 million (€11 million). The main objective of this round of financing was to launch the company's international expansion plan and structure its operations while leading innovations in the ultrasound probe sector. The investment is expected to aid the company in its long-term growth and provide advanced solutions to healthcare professionals to enhance the quality of care provided to the patients.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work